Comparing comparators: a look at control arms in kidney cancer studies over the years

In the past decade, an increasing number of frequently positive randomised clinical trials have been completed, allowing new consideration of the present therapeutic armamentarium for advanced renal cell carcinoma. These studies were predominantly designed to compare the experimental drugs with 1 of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bracarda, S, Porta, C, Sisani, M, Marrocolo, F, Paglino, C, Hamzaj, A, D Buono, S, Sternberg, C N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453592/
https://www.ncbi.nlm.nih.gov/pubmed/25375270
http://dx.doi.org/10.1038/bjc.2014.240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453592/
https://www.ncbi.nlm.nih.gov/pubmed/25375270
http://dx.doi.org/10.1038/bjc.2014.240

Ejemplares similares